Kermit E. Osserman

2.8k total citations · 1 hit paper
49 papers, 2.1k citations indexed

About

Kermit E. Osserman is a scholar working on Neurology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Kermit E. Osserman has authored 49 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Neurology, 10 papers in Oncology and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Kermit E. Osserman's work include Myasthenia Gravis and Thymoma (38 papers), Parkinson's Disease and Spinal Disorders (15 papers) and Cancer Treatment and Pharmacology (10 papers). Kermit E. Osserman is often cited by papers focused on Myasthenia Gravis and Thymoma (38 papers), Parkinson's Disease and Spinal Disorders (15 papers) and Cancer Treatment and Pharmacology (10 papers). Kermit E. Osserman collaborates with scholars based in United States and United Kingdom. Kermit E. Osserman's co-authors include William L. Nastuk, Gabriel Genkins, A E Kark, A Strauss, Otto J. Plescia, Angelos E. Papatestas, Max Ellenberg, Beatrice Carrier Seegal, Konrad C. Hsu and Peter M. Burkholder and has published in prestigious journals such as New England Journal of Medicine, JAMA and Annals of Internal Medicine.

In The Last Decade

Kermit E. Osserman

47 papers receiving 1.7k citations

Hit Papers

Immunofluorescence Demons... 1960 2026 1982 2004 1960 100 200 300

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Kermit E. Osserman 1.5k 364 318 200 162 49 2.1k
Choong Hyun Kim 332 0.2× 286 0.8× 70 0.2× 78 0.4× 204 1.3× 85 1.1k
Wallace G. Campbell 120 0.1× 429 1.2× 219 0.7× 95 0.5× 251 1.5× 66 1.8k
Abe T 211 0.1× 282 0.8× 37 0.1× 90 0.5× 88 0.5× 315 1.2k
Charles Ragan 116 0.1× 354 1.0× 518 1.6× 126 0.6× 57 0.4× 59 1.8k
Giuseppe Cardillo 240 0.2× 463 1.3× 57 0.2× 93 0.5× 144 0.9× 64 1.6k
Stefan M. Weiner 226 0.2× 220 0.6× 46 0.1× 274 1.4× 208 1.3× 56 1.4k
Itzhak Rosner 93 0.1× 259 0.7× 321 1.0× 136 0.7× 99 0.6× 74 1.9k
Donald Gribetz 73 0.1× 246 0.7× 168 0.5× 66 0.3× 49 0.3× 37 1.0k
Marcello Mancini 161 0.1× 182 0.5× 296 0.9× 100 0.5× 115 0.7× 76 1.5k
Vito D. Corleto 849 0.6× 1.0k 2.8× 150 0.5× 65 0.3× 1.2k 7.6× 104 2.8k

Countries citing papers authored by Kermit E. Osserman

Since Specialization
Citations

This map shows the geographic impact of Kermit E. Osserman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kermit E. Osserman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kermit E. Osserman more than expected).

Fields of papers citing papers by Kermit E. Osserman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kermit E. Osserman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kermit E. Osserman. The network helps show where Kermit E. Osserman may publish in the future.

Co-authorship network of co-authors of Kermit E. Osserman

This figure shows the co-authorship network connecting the top 25 collaborators of Kermit E. Osserman. A scholar is included among the top collaborators of Kermit E. Osserman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kermit E. Osserman. Kermit E. Osserman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brookler, Kenneth H., et al.. (1972). Nonsuppurative Otitis Media in Myasthenia Gravis. Archives of Otolaryngology - Head and Neck Surgery. 96(6). 535–537. 6 indexed citations
2.
Papatestas, Angelos E., Kermit E. Osserman, & A E Kark. (1972). The effects of thymectomy on the prognosis in myasthenia gravis.. PubMed. 38(6). 586–93. 13 indexed citations
3.
Papatestas, Angelos E., et al.. (1971). Studies in myasthenia gravis: Effects of thymectomy. The American Journal of Medicine. 50(4). 465–474. 142 indexed citations
4.
Papatestas, Angelos E., Kermit E. Osserman, & A E Kark. (1971). The Relationship Between Thymus and Oncogenesis. British Journal of Cancer. 25(4). 635–645. 75 indexed citations
5.
Kornfeld, Peter, Robert L. Wolf, Arthur J. Samuels, & Kermit E. Osserman. (1971). The effect of chronic pyridostigmine administration on pyridostigmine‐ 14 C metabolism in myasthenia gravis. Neurology. 21(5). 550–550. 8 indexed citations
6.
Kornfeld, Peter, Arthur J. Samuels, Robert L. Wolf, & Kermit E. Osserman. (1970). Metabolism of 14 C‐labeled pyridostigmine in myasthenia gravis. Neurology. 20(7). 634–634. 26 indexed citations
7.
Kornfeld, Peter, Avril V. Somlyo, & Kermit E. Osserman. (1969). Role of Calcium in Myasthenia Gravis. Archives of Neurology. 21(5). 466–470. 10 indexed citations
8.
Lang, R., et al.. (1969). Studies in Myasthenia Gravis. Incidence of Muscle-precipitating Antibodies Correlated with Positive Immunofluorescence. American Journal of Clinical Pathology. 51(2). 238–244. 8 indexed citations
9.
Foldes, Francis F., et al.. (1968). A new curare test for the diagnosis of myasthenia gravis.. PubMed. 203(9). 649–53. 21 indexed citations
10.
Perlo, Vincent P., David C. Poskanzer, Robert S. Schwab, et al.. (1966). Myasthenia gravis. Neurology. 16(5). 431–431. 163 indexed citations
11.
Osserman, Kermit E., et al.. (1965). STUDIES IN MYASTHENIA GRAVIS: IMMUNOFLUORESCENT TAGGING OF MUSCLE STRIATION WITH ANTIBODY FROM SERUMS OF 256 MYASTHENIC PATIENTS*. Annals of the New York Academy of Sciences. 124(2). 730–743. 27 indexed citations
12.
Nastuk, William L., Otto J. Plescia, & Kermit E. Osserman. (1960). Changes in Serum Complement Activity in Patients with Myasthenia Gravis.. Experimental Biology and Medicine. 105(1). 177–184. 206 indexed citations
13.
Strauss, A, Beatrice Carrier Seegal, Konrad C. Hsu, et al.. (1960). Immunofluorescence Demonstration of a Muscle Binding, Complement-Fixing Serum Globulin Fraction in Myasthenia Gravis.. Experimental Biology and Medicine. 105(1). 184–191. 322 indexed citations breakdown →
14.
Osserman, Kermit E.. (1959). �ber die Myasthenia gravis. Journal of Molecular Medicine. 37(1). 7–12. 1 indexed citations
15.
Osserman, Kermit E.. (1958). Studies in Myasthenia Gravis. A M A Archives of Internal Medicine. 102(1). 72–72. 73 indexed citations
16.
Osserman, Kermit E.. (1955). Progress report on mestinon bromide (pyridostigmine bromide). The American Journal of Medicine. 19(5). 737–739. 19 indexed citations
17.
Osserman, Kermit E.. (1953). STUDIES IN MYASTHENIA GRAVIS. A M A Archives of Neurology & Psychiatry. 70(3). 385–385. 21 indexed citations
18.
Ellenberg, Max, Kermit E. Osserman, & Herbert Pollack. (1952). Hyperglycemia in Coronary Thrombosis. Diabetes. 1(1). 16–21. 28 indexed citations
19.
Osserman, Kermit E.. (1952). RAPID DIAGNOSTIC TEST FOR MYASTHENIA GRAVIS. Journal of the American Medical Association. 150(4). 265–265. 68 indexed citations
20.
Osserman, Kermit E. & Henry Dolger. (1951). OBESITY IN DIABETES: A STUDY OF THERAPY WITH ANOREXIGENIC DRUGS. Annals of Internal Medicine. 34(1). 72–79. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026